GlassScriptPhysician profile
Tedla T Tessema
NPI 1952573370
$10,744.20
in general payments reported to CMS, 2019-2025
15 companies · $2,108 in 2025
The $2,108 reported for 2025 was more than what 78% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $243 · 2020: $49.77 · 2021: $11.75 · 2022: $25.95 · 2023: $127 · 2024: $8,179 · 2025: $2,108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,086 · Education: $3,877 · Food and Beverage: $1,443 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,085.68 |
| Education | $3,876.59 |
| Food and Beverage | $1,442.97 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,163.63 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $1,942.23 | 2025 | Ribfix Titan, Advantagerib, Tmj System |
| Integra Lifesciences Corporation | $102.40 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ethicon US, LLC | $93.51 | 2019-2024 | Echelon Flex |
| Kerecis Limited | $88.71 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Acell, INC. | $73.53 | 2019 | |
| Haemonetics Corporation | $70.66 | 2023-2025 | Teg6s Hemostasis System |
| Boston Scientific Corporation | $46.06 | 2025 | Spyglass Discover |
| Davol INC. | $35.00 | 2023 | Phasix Mesh |
| Teleflex LLC | $26.47 | 2025 | Deknatel |
| Aroa Biosurgery Incorporated | $26.30 | 2025 | |
| Covidien LP | $23.42 | 2019 | |
| Solventum Corporation | $22.30 | 2024 | V.A.C.Ulta |
| Tei Biosciences INC | $16.85 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tedla Tessema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.